{"id":100030,"date":"2026-06-04T17:00:00","date_gmt":"2026-06-04T17:00:00","guid":{"rendered":"https:\/\/naveris.com\/newnaveris\/?page_id=100006"},"modified":"2026-06-05T20:28:52","modified_gmt":"2026-06-05T20:28:52","slug":"press-releases","status":"publish","type":"page","link":"https:\/\/naveris.com\/newnaveris\/index.php\/about-naveris\/news\/press-releases\/","title":{"rendered":"Press Releases"},"content":{"rendered":"[vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; equal_height=&#8221;yes&#8221; content_placement=&#8221;bottom&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_image=&#8221;48376&#8243; background_image_preload=&#8221;true&#8221; bg_image_type=&#8221;default&#8221; bg_position=&#8221;center center&#8221; background_image_loading=&#8221;default&#8221; bg_repeat=&#8221;no-repeat&#8221; scene_position=&#8221;center&#8221; top_padding=&#8221;7%&#8221; bottom_padding=&#8221;8%&#8221; text_color=&#8221;light&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; row_position_desktop=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; color_overlay=&#8221;#17476b&#8221; color_overlay_2=&#8221;rgba(0,21,22,0.58)&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; enable_shape_divider=&#8221;true&#8221; shape_divider_color=&#8221;#21B7B6&#8243; shape_divider_position=&#8221;bottom&#8221; shape_divider_height=&#8221;40&#8243; bg_image_animation=&#8221;fade-in&#8221; parallax_bg=&#8221;true&#8221; parallax_bg_speed=&#8221;fast&#8221; shape_type=&#8221;curve&#8221; gradient_type=&#8221;default&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; flex_gap_desktop=&#8221;10px&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; font_color=&#8221;#ffffff&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/2&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][nectar_responsive_text inherited_font_style=&#8221;h1&#8243; text_color=&#8221;#FFFFFF&#8221; text_direction=&#8221;default&#8221; font_size_desktop=&#8221;50px&#8221; font_line_height=&#8221;1.3em&#8221;]\n<h1>The Biology of HPV+ Cancer,<br \/>\nEngineered into a Blood Test.<\/h1>\n[\/nectar_responsive_text][nectar_btn size=&#8221;large&#8221; button_style=&#8221;regular&#8221; button_color_2=&#8221;Extra-Color-2&#8243; color_override=&#8221;#FFFFFF&#8221; solid_text_color_override=&#8221;#25476A&#8221; icon_family=&#8221;none&#8221; text=&#8221;LEARN MORE&#8221; margin_top=&#8221;20px&#8221;][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;38&#8243;][\/vc_column][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; flex_gap_desktop=&#8221;10px&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/2&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][\/vc_column][\/vc_row][vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; equal_height=&#8221;yes&#8221; content_placement=&#8221;middle&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_color=&#8221;#E2E2E2&#8243; scene_position=&#8221;center&#8221; top_padding=&#8221;6%&#8221; bottom_padding=&#8221;7%&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; row_position_desktop=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221; gradient_type=&#8221;default&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; flex_gap_desktop=&#8221;10px&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][nectar_responsive_text inherited_font_style=&#8221;default&#8221; text_color=&#8221;#25476A&#8221; text_direction=&#8221;default&#8221;]\n<h2>Press Releases.<\/h2>\n<ul>\n<li><strong>January 9, 2026<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-to-highlight-new-publications-at-the-44th-annual-j-p-morgan-healthcare-conference\/' target='_blank'>Naveris to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference<\/a><\/li>\n<li><strong>November 17, 2025<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-announces-medicare-coverage-of-the-navdx-test-in-anal-cancer-molecular-residual-disease-surveillance\/' target='_blank'>Naveris Announces Expanded Medicare Coverage for the NavDx&#174; Test in Identification of Molecular Residual Disease of Anal Squamous Cell Carcinoma<\/a><\/li>\n<li><strong>January 10, 2025<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-announces-expansion-of-the-navdx-test-in-anal-cancer-molecular-residual-disease-surveillance\/' target='_blank'>Naveris Announces Expansion of the NavDx&#174; Test in Anal Cancer Molecular Residual Disease Surveillance<\/a><\/li>\n<li><strong>October 9, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-announces-expanded\/' target='_blank'>Naveris Announces Expanded Commercial Payor Coverage for NavDx Test from Blue Shield of California<\/a><\/li>\n<li><strong>September 28, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-to-showcase-advances\/' target='_blank'>Naveris to Showcase Advances in Precision Surveillance for HPV-Associated Oropharyngeal Cancer Using the NavDx&#174; Test at the 2024 ASTRO Annual Meeting<\/a><\/li>\n<li><strong>September 27, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-presents-new-data\/' target='_blank'>Naveris Presents New Data on the NavDx&#174; test for HPV-Associated Oropharyngeal Cancer at the 2024 AAO-HNS Annual Meeting<\/a><\/li>\n<li><strong>June 27, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/new-multicenter-study-highlights-use-of-the-navdx-test-in-resolving-clinically-indeterminate-findings\/' target='_blank'>New Multicenter Study Highlights Use of the NavDx&#174; Test in Resolving Clinically Indeterminate Findings<\/a><\/li>\n<li><strong>May 29, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-to-present-new-data-highlighting-clinical-utility-of-the-navdx-test-at-the-2024-asco-annual-meeting\/' target='_blank'>Naveris to Present New Data Highlighting Clinical Utility of the NavDx&#174; Test at the 2024 ASCO Annual Meeting<\/a><\/li>\n<li><strong>April 24, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-announces-launch-of-phase-ii-clinical-study-in-mrd-head-and-neck-cancer\/' target='_blank'>Naveris Announces Launch of Phase II Clinical Study in MRD+ Head and Neck Cancer<\/a><\/li>\n<li><strong>March 21, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-awarded-adlt-status-by-cms-for-the-navdx-test\/' target='_blank'>Naveris Awarded ADLT Status by CMS for the NavDx&#174; Test<\/a><\/li>\n<li><strong>March 14, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-announces-new-data-at-eurogin-international-multidisciplinary-hpv-congress-2024\/' target='_blank'>Naveris Announces New Data at EUROGIN International Multidisciplinary HPV Congress 2024<\/a><\/li>\n<li><strong>March 1, 2024<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-unveils-navigate-hpv-a-groundbreaking-registry-to-advance-hpv-driven-cancer-diagnosis-and-treatment\/' target='_blank'>Naveris Unveils NAVigate-HPV: A Groundbreaking Registry to Advance HPV-Driven Cancer Diagnosis and Treatment<\/a><\/li>\n<li><strong>November 30, 2023<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-receives-medicare-coverage-for-navdx-test\/' target='_blank'>Naveris Receives Medicare Coverage for NavDx&#174; Test<\/a><\/li>\n<li><strong>September 19, 2022<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-inc-raises-51-million-to-advance-commercialization-of-navdx\/' target='_blank'>Naveris, Inc. Raises $51 Million to Advance Commercialization of NavDx<\/a><\/li>\n<li><strong>December 15, 2020<\/strong> &#8212; <a href='https:\/\/naveris.com\/press-release\/naveris-inc-raises-19-million-in-financing-to-advance-and-commercialize-blood-tests-for-early-detection-of-hpv-and-other-viral-related-cancers-i\/' target='_blank'>Naveris, Inc. Raises $19 Million in Financing to Advance and Commercialize Blood Tests for Early Detection of HPV and Other Viral-Related Cancers<\/a><\/li>\n<\/ul>\n[\/nectar_responsive_text][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; equal_height=&#8221;yes&#8221; content_placement=&#8221;bottom&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_image=&#8221;48376&#8243; background_image_preload=&#8221;true&#8221; bg_image_type=&#8221;default&#8221; bg_position=&#8221;center center&#8221; background_image_loading=&#8221;default&#8221; bg_repeat=&#8221;no-repeat&#8221; scene_position=&#8221;center&#8221; top_padding=&#8221;7%&#8221; bottom_padding=&#8221;8%&#8221; text_color=&#8221;light&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; row_position_desktop=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; color_overlay=&#8221;#17476b&#8221; color_overlay_2=&#8221;rgba(0,21,22,0.58)&#8221; overlay_strength=&#8221;0.3&#8243;&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":96,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-100030","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/pages\/100030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/comments?post=100030"}],"version-history":[{"count":1,"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/pages\/100030\/revisions"}],"predecessor-version":[{"id":100127,"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/pages\/100030\/revisions\/100127"}],"up":[{"embeddable":true,"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/pages\/96"}],"wp:attachment":[{"href":"https:\/\/naveris.com\/newnaveris\/index.php\/wp-json\/wp\/v2\/media?parent=100030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}